在没有基因组整合的情况下,通过杆切换调节的RNA病毒载体对干细胞命运进行可扩展的控制
Narae Kim1, Yohei Yokobayashi1
1Nucleic Acid Chemistry and Engineering Unit, Okinawa Institute of Science and Technology Graduate University, Onna, Okinawa 904 0495, Japan.
概括
研究人员开发了新的RNA病毒载体,用于在小鼠胚胎干细胞 (mESCs) 中进行可扩展,无集成的转基因表达. 这些载体使时间控制和稳定维护成为可能,克服了干细胞应用当前基因传递方法的局限性.
科学领域:
- 干细胞生物学 干细胞生物学
- 基因治疗是一种基因疗法.
- 分子病毒学分子病毒学.
背景情况:
- 转基因表达对于调节干细胞特性和分化至关重要.
- 目前的载体面临着诸如基因组整合,短暂表达和缺乏时间控制等挑战,限制了临床使用.
研究的目的:
- 开发一种新的,无集成的载体系统,用于小鼠胚胎干细胞 (mESCs) 中可扩展和时间调节的转基因表达.
主要方法:
- 利用基于RNA病毒的载体,使用小分子调节的核糖开关和药物选择标记器进行工程设计.
- 在mESC中证明了维护多能性 (Nanog表达) 和诱导分化 (Myod1表达) 的矢量实用性.
主要成果:
- 在mESCs中成功实现了可扩展和无集成的转基因表达.
- 启用了基因表达的时间调节和在增殖干细胞中保持稳定的载体.
- 通过保持多能性和诱导肌原分化而未改变mESC基因组,展示了功能应用.
结论:
- 这种新一类的RNA病毒载体为先进的干细胞工程和治疗应用提供了一个有前途的平台.
- 载体系统的无集成性和临时调节性克服了现有的基因传递方法的关键局限性.
相关概念视频
Experimental RNAi
6.0K
RNA interference (RNAi) is a cellular mechanism that inhibits gene expression by suppressing its transcription or activating the RNA degradation process. The mechanism was discovered by Andrew Fire and Craig Mello in 1998 in plants. Today, it is observed in almost all eukaryotes, including protozoa, flies, nematodes, insects, parasites, and mammals. This precise cellular mechanism of gene silencing has been developed into a technique that provides an efficient way to identify and determine the...
6.0K
siRNA - Small Interfering RNAs
16.6K
Small interfering RNAs, or siRNAs, are short regulatory RNA molecules that can silence genes post-transcriptionally, as well as the transcriptional level in some cases. siRNAs are important for protecting cells against viral infections and silencing transposable genetic elements.
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the...
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the...
16.6K
Regulation of Hematopoietic Stem Cells
3.1K
All blood and immune cells are produced from the multipotent hematopoietic stem cells (HSCs) by the process of hematopoiesis. However, they all have a limited life span. In addition, many are depleted in immune surveillance or combatting an injury or infection. This makes blood one of the most regenerative tissues. Hematopoiesis helps replenish these blood and immune cells, restoring the body's normal functioning. However, overproduction of blood and immune cells can make them cancerous or...
3.1K


